These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35665716)

  • 1. Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis.
    Johnson TP; Nath A
    Curr Opin Infect Dis; 2022 Jun; 35(3):223-230. PubMed ID: 35665716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated neurological disorders: a guide to pharmacotherapy.
    Tan IL; McArthur JC
    CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.
    Minagar A; Commins D; Alexander JS; Hoque R; Chiappelli F; Singer EJ; Nikbin B; Shapshak P
    Mol Diagn Ther; 2008; 12(1):25-43. PubMed ID: 18288880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of HIV-associated disease of the central nervous system.
    Mallard J; Williams KC
    Handb Clin Neurol; 2018; 152():41-53. PubMed ID: 29604983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
    Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
    Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics.
    Olivier IS; Cacabelos R; Naidoo V
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NeuroAIDS in sub-Saharan Africa: a clinical review.
    Alkali NH; Bwala SA; Nyandaiti YW; Danesi MA
    Ann Afr Med; 2013; 12(1):1-10. PubMed ID: 23480988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.
    Spudich S; González-Scarano F
    Cold Spring Harb Perspect Med; 2012 Jun; 2(6):a007120. PubMed ID: 22675662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-Associated Neurologic Disorders and Central Nervous System Opportunistic Infections in HIV.
    Le LT; Spudich SS
    Semin Neurol; 2016 Aug; 36(4):373-81. PubMed ID: 27643907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review.
    Williams ME; Stein DJ; Joska JA; Naudé PJW
    J Neuroimmunol; 2021 Sep; 358():577649. PubMed ID: 34280844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathogenesis of human immunodeficiency virus infection.
    Sillman B; Woldstad C; Mcmillan J; Gendelman HE
    Handb Clin Neurol; 2018; 152():21-40. PubMed ID: 29604978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered.
    Gelman BB
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):272-9. PubMed ID: 25860316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.
    Vera JH; Ridha B; Gilleece Y; Amlani A; Thorburn P; Dizdarevic S
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):895-902. PubMed ID: 28058461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system.
    Calado M; Ferreira R; Pires D; Santos-Costa Q; Anes E; Brites D; Azevedo-Pereira JM
    Rev Med Virol; 2024 May; 34(3):e2534. PubMed ID: 38588024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic diseases in HIV-infected patients.
    Bilgrami M; O'Keefe P
    Handb Clin Neurol; 2014; 121():1321-44. PubMed ID: 24365422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Wright EJ
    Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NeuroAIDS in children.
    Wilmshurst JM; Hammond CK; Donald K; Hoare J; Cohen K; Eley B
    Handb Clin Neurol; 2018; 152():99-116. PubMed ID: 29604987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-related neurocognitive impairment--a review.
    Rackstraw S
    Psychol Health Med; 2011 Oct; 16(5):548-63. PubMed ID: 21745034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.